Xinzhuang Zhang
Biographic Data
| ID | 7302350 |
|---|---|
| NAME | Xinzhuang Zhang |
| GIVEN NAMES | Xinzhuang |
| FAMILY NAME | Zhang |
| SIGNATURE | ZHANG X |
| AFFILIATIONS | Kanion Pharmaceutical (China) |
| ORCID | 0000-0002-0833-6751 |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Exploring therapeutic mechanisms of San-Huang-Tang in nonalcoholic fatty liver disease through network pharmacology and experimental validation
Dissecting the novel mechanism of reduning injection in treating Coronavirus Disease 2019 (Covid-19) based on network pharmacology and experimental verification
RDNI can regulate ACE2, Mpro and PLP in COVID-19. The underlying mechanisms of RDNI in the treatment for COVID-19 may be related to the modulation of the cytokine levels and inflammation and its antipyretic activity by regulating the expression of MAPKs, PKC and p65 nuclear factor NF-κB
Insight into the molecular mechanism of a herbal injection by integrating network pharmacology and in vitro
No prominent works on this page.
Insight into the molecular mechanism of a herbal injection by integrating network pharmacology and in vitro
Dissecting the novel mechanism of reduning injection in treating Coronavirus Disease 2019 (Covid-19) based on network pharmacology and experimental verification
RDNI can regulate ACE2, Mpro and PLP in COVID-19. The underlying mechanisms of RDNI in the treatment for COVID-19 may be related to the modulation of the cytokine levels and inflammation and its antipyretic activity by regulating the expression of MAPKs, PKC and p65 nuclear factor NF-κB
Exploring therapeutic mechanisms of San-Huang-Tang in nonalcoholic fatty liver disease through network pharmacology and experimental validation
Biochemistry (3 works) · Medicine (3 works) · Pharmacology (3 works) · Signal transduction (3 works) · Chemistry (2 works) · Disease (2 works) · Gene (2 works) · In vitro (2 works) · MAPK/ERK pathway (2 works) · Bioinformatics (1 works)